Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma - Concepedia

Concepedia

Publication | Open Access

Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma

DOI Full Paper Access

38

Citations

21

References

2019

Year

Si Sun, Hui Yu, Huijie Wang, Hai Zhang, Xianghua Wu, Jialei Wang, Jianhua Chang

Oncology Research and Treatment

Abstract

The combination of S-1 plus cisplatin was a well-tolerated and convenient chemotherapy regimen with promising efficacy.

References

	Year	Citations

Page 1